Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Heroin is a potent opioid that offers no substantial advantages over morphine. In the UK it is the preferred parenteral opioid for subcutaneous administration to cachectic cancer patients, because of its high solubility.
The prevalence of heroin as a drug of abuse has been reviewed [ ]. There are over 1 million heroin addicts in the USA. The lifetime prevalence among those aged 12–25 years continues to increase gradually.
High-dose diamorphine has been compared with morphine in a double-blind, crossover, randomized study in 39 intravenous opioid users who were allocated to either morphine 3% solution or diamorphine 2% solution, gradually increasing up to an individual maintenance dose adjusted to meet the patient’s subjective needs [ ]. Those who started with diamorphine and subsequently switched to morphine terminated prematurely owing to excessive histamine reactions, all of which occurred during crossover to morphine. Symptoms included severe pruritus, flushing, swelling, urticaria, severe headaches, nausea, general malaise, hypotension, and tachycardia. Only 44% of the original cohort finished the 6-week study (14 getting diamorphine at the end and three getting morphine). Average daily doses were 491 mg for diamorphine and 597 mg for morphine. These results suggest that diamorphine produces fewer adverse reactions than morphine and may be preferable for high-dose maintenance prescription. However, the study was very small and the subject selection was biased, as were the variables used to determine a successful outcome. The result was contrary to all the well-established pharmacological facts, and the authors did not mention the risks associated with high doses of short-acting opioids.
In a randomized, double-blind study, 64 patients undergoing total knee arthroplasty received either intrathecal morphine 0.3 mg or intrathecal diamorphine, 0.3 mg in 0.3 ml, with 2–2.5 ml of 0.5% heavy spinal bupivacaine [ ]. The patients given morphine had significantly greater analgesia at 4, 8, and 12 hours postoperatively. The incidence of opioid-related adverse reactions was not significantly different between the groups.
In a single-blind, randomized, controlled study, 70 patients scheduled for elective cesarean section under spinal anesthesia using hyperbaric bupivacaine 0.5% received intrathecal fentanyl 20 micrograms, intrathecal diamorphine 300 micrograms, or 0.9% saline [ ]. Significantly less intraoperative and postoperative “analgesic control” was required in the opioid groups, especially in those given diamorphine. Diamorphine produced longer-lasting analgesia than fentanyl (12 hours versus 1 hour). Nausea, vomiting, and pruritus occurred relatively infrequently, with no differences between the groups; sedation was more frequent with fentanyl.
In two separate open, randomized, controlled but unblinded trials, 549 patients were divided into five treatment groups. In the first study there were 375 patients in three groups:
methadone alone for 12 months (controls);
methadone plus inhaled heroin for 12 months;
methadone alone for 6 months followed by methadone plus inhaled heroin for 6 months.
In the second study there were 174 patients in two similar experimental groups in whom injectable rather than inhaled heroin was used [ ]. A response to treatment was defined as at least a 40% improvement in physical, mental, or social domains of quality of life, if not accompanied by a substantial (over 20%) increase in the use of another illicit drug, such as cocaine or amphetamines. After 12 months those who took methadone and heroin (smoked or injected) had significantly better outcomes. The incidences of adverse reactions (constipation and drowsiness) were similar in all the groups. However, owing to the limitations of the study and the complex nature of drug dependence, the therapeutic outcomes could not be justifiably and solely attributed to the specific drug(s).
In a randomized, double-blind study, 14 patients who underwent elective surgery for correction of bilateral arthritic deformities of the feet received 15 ml of 0.9% saline containing diamorphine 2.5 mg into the cannula in one foot and 15 ml of saline into the other foot [ ]. Intravenous regional diamorphine did not improve postoperative pain relief or secondary hyperalgesia. There were no significant adverse reactions.
Cardiomyopathy has been attributed to heroin.
A 23-year-old man developed generalized weakness and edema in both legs after using heroin. Over the next 24 hours he had reduced urine output and respiratory distress, which required intubation and mechanical ventilation. A chest X-ray showed pulmonary edema. Electrocardiography showed T wave inversion in leads V3–6. He had raised activities of AsT (1337 U/l), AlT (1732 U/l), LDH (5280 U/l), creatine kinase (72500 U/l), and creatine kinase MB isoenzyme (2225 U/l), and raised serum concentrations of creatinine (600 μmol/l) and urea (27 mmol/l). An echocardiogram showed severe global systolic left ventricular dysfunction with an ejection fraction of 15%. Cardiac catheterization showed pulmonary edema. He was given intravenous dobutamine and continuous venovenous hemofiltration. His cardiac output gradually improved. On day 8 he developed abdominal pain and a fall in hematocrit. A large retroperitoneal hematoma was found on an abdominal CT scan. Angiography showed multiple small aneurysms in the upper of the two left renal arteries. Embolization of the vessel was successful and he improved gradually. Four months later he still had a reduced left ventricular ejection fraction of 45%.
“Chasing the dragon,” or inhaling heroin vapor through a straw, is a technique by which heroin users avoid the risks of injection. In Amsterdam, 85% of heroin users smoke or chase the drug. Pulmonary function can be affected by heroin inhalation. It can depress the respiratory center, release histamine (which can trigger asthma), result in septic emboli, and increase susceptibility to infectious diseases, such as tuberculosis and pneumonia. In 100 methadone maintenance users, lung function and shortness of breath were evaluated using spirometry and clinical history [ ]. Impaired lung function and shortness of breath correlated with chronic heroin smoking.
Heroin insufflation has been identified as a trigger for asthma [ ]. Of 23 patients aged 50 years and younger who were admitted to Cook County Hospital during 6 months with a primary diagnosis of asthma exacerbation, 13 reported heroin use and identified it as an asthma trigger, four reported heroin use but did not associate it with asthma exacerbation, and six had no recent history of heroin use. The patients with heroin-triggered symptoms stated that asthma exacerbation had not occurred on first use but had developed over time. Five of the seven patients whose asthma developed in adulthood reported that their heroin use had predated their asthma.
The same group of researchers then conducted a retrospective case–control study of all asthma admissions in patients under 50 over a period of 2 years. The charts of patients admitted with diabetic ketoacidosis during the same period were used as controls. Drug histories and urine drug screens were used to identify heroin users. Of 104 admissions (84 patients), 38 acknowledged a history of heroin use and 34 returned a urine drug screen that was positive for opiates. Both a history of heroin use and a positive urine drug screen were significantly more common in those with asthma than in those with diabetic ketoacidosis.
These two studies taken together suggest that heroin insufflation commonly triggers asthma, and that heroin use is more prevalent in patients with asthma. It is possible that heroin causes bronchospasm or pulmonary mast cell degranulation; alternatively, since heroin becomes a trigger over a long period of time, allergic sensitization could be involved. Another possibility is that the cutting agents and contaminants in street heroin act as irritants to the airways.
In a retrospective study of the case notes of patients who had been admitted to hospital with acute attacks of asthma, there was a high prevalence of heroin use – 15% had used only heroin and another 16% had used both heroin and cocaine [ ]. Heroin users had been intubated more often than non-drug users (17% versus 2.3%). Similarly, more heroin users were admitted to ICU than non-users (21% versus 12%). However, they did not spend more time receiving mechanical ventilation or being in hospital. These findings suggest that heroin induced some degree of bronchoconstriction and respiratory depression, which worsened the initial presentation of asthma.
Heroin-induced pulmonary edema, or “heroin lung” [ ], is a serious complication, which may be due to release of histamine, with increased pulmonary lymph flow and capillary permeability. There have been 27 reports of non-fatal heroin overdose associated with non-cardiogenic pulmonary edema [ ]. In a retrospective case–control study there were 23 heroin fatalities and 12 controls with sudden cardiac deaths [ ]. The authors tried to verify that defects of the alveolar capillary membranes and/or an acute anaphylactic reaction can lead to pulmonary congestion, edema, and hemorrhages. There were defects of the epithelial and endothelial basal laminae of the alveoli in both groups. There was an insignificant increase in IgE-positive cells in the heroin group. The findings suggested that heroin-associated lung edema is generally not caused by an anaphylactic reaction.
Bilateral pulmonary edema associated with heroin abuse has been reported several times [ ]. Bronchospasm has been noted following the use of street heroin, perhaps due to contaminants [ ].
Delayed onset oculogyric crisis and generalized dystonia occurred in a 19-year-old man after intranasal heroin use, possibly due to bilateral hypoxic infarction of the pallidum and pallidothalamic tracts [ ].
There has been one report of mixed transcortical aphasia attributed to heroin [ ].
Myoclonic spasm has been reported about 24 hours after withdrawal of an epidural infusion of diamorphine [ ].
Demyelination has been attributed to diamorphine [ ].
A 41-year-old chronic diamorphine user developed an unsteady gait and dysarthria over 2 weeks, followed by severe cerebellar ataxia and moderate dysmetria of the arms and legs. An MRI scan suggested myelin damage, with symmetrical involvement of the cerebellar hemispheres and decussation of the superior cerebellar peduncles, the corticospinal tracts, and the centrum semiovale, suggesting spongiform leukoencephalopathy. Two years later having taken no more diamorphine he was improved, with minor regression of the MRI lesions, especially the white matter lesions.
Myelopathy has been reported after intranasal insufflation of diamorphine [ ].
A 52-year-old man with a history of diamorphine abuse presented with sudden paraplegia a few hours after intranasal insufflation. He had flaccid paralysis of both legs, acute urinary retention, and reduced rectal tone. Deep tendon reflexes were absent and plantar responses were extensor. An MRI scan of the spine and an immunoglobulin profile supported the conclusion that this was a case of acute myelopathy with an immunopathological cause, involving a protein specific to spinal cord parenchyma, triggering acute local inflammation, ischemia, and tissue damage. Seven weeks later he recovered normal neurological function.
This case of heroin myelopathy is similar to other reported cases, except that this case occurred with intranasal rather than intravenous use. The MRI findings were consistent with a transverse myelitis. The authors suggested that hypersensitivity and an immune-mediated attack on the spinal cord was the likely mechanism of injury.
Reflex sympathetic dystrophy, in which there is an excessive or abnormal sympathetic nervous system response in a limb, has been associated with rhabdomyolysis secondary to heroin abuse [ ].
A 37-year-old male heroin smoker developed tea-colored urine and pain, swelling, and tenderness in both feet. He had acute renal insufficiency and rhabdomyolysis and was treated with hemodialysis. Urine toxicology was negative. He also had persistent, burning pain in both feet, with cool, pale, thin skin on both legs, a mild reduction in sensation on the lateral aspects of the lower legs and diminished bilateral knee and ankle reflexes. Walking was restricted, with limited range of movement owing to the severe pain. His feet would swell and redden after a 5-meter walk, suggesting loss of sympathetic regulation. Nerve conduction velocity studies of the tibial, peroneal, and sural nerves were abnormal. Radiographs showed mildly reduced bone mineralization in the legs. Three-phase bone scintigraphy showed diffusely increased radiotracer accumulation over both feet in all three phases, as found in reflex sympathetic dystrophy. The diagnosis was confirmed by local anesthetic sympathetic blockade. Nasal calcitonin spray led to pain relief 2 months later. A follow-up three-phase bone scintigram showed less radiotracer uptake, consistent with a good response to calcitonin therapy.
Substance-induced polyradiculopathy has been described in a 23-year-old Caucasian man after administration of high doses of heroin and cocaine into the left internal carotid artery [ ].
Six patients developed some form of neuropathy following heroin use [ ]. Four developed a plexopathy and two a symmetric distal axonal sensorimotor neuropathy. Five also had rhabdomyolysis with high creatinine kinase activities.
Neurotoxicity resulting from chronic heroin use has been explored in 15 heroin-dependent patients [ ]. These patients had reduced concentrations of nerve growth factor and brain-derived neurotrophic factor, both of which are postulated to influence the survival of neurons, suggesting that they may have a role in neurotoxicity associated with heroin use.
A 45-year-old man developed a generalized dyskinetic syndrome, impaired vision, and severe parkinsonism 24 hours after snorting heroin [ ]. Brain imaging showed grey matter lesions in the basal ganglia and cerebral cortex. It is unclear whether these lesions were caused by the heroin itself or by additives.
A rare consequence of inhaling heated heroin (“chasing the dragon”) is a progressive spongiform leukoencephalopathy. The first cases of leukoencephalopathy due to inhalation of heroin pyrolysate were described in the Netherlands in 1982. The first three cases in the USA were reported in 1996 [ ].
The condition has three stages, progressing from cerebellar signs and motor restlessness to pyramidal and pseudobulbar signs and, in a minority of patients (about 25%), to a terminal stage characterized by spasms, hypotonic paresis, and ultimately death. Symmetrical spongiform degeneration occurs, particularly in the cerebral and cerebellar white matter and in corticospinal and solitary tracts. Involvement of the cerebellum and the posterior limb of the internal capsule, with sparing of the anterior limb, appear to be characteristic, helping to distinguish this condition from other causes of leukoencephalopathy. Neuroimaging techniques contribute significantly to the management of such patients, as is evident from recent cases.
A 16-year-old man was found at home drowsy 36 hours after smoking heroin for the first time [ ]. He had a gaze paresis and sensorimotor hemiplegia on the left side. A CT scan showed bilateral hypodense lesions in the globus pallidus. An MRI scan 5 days later showed symmetrical hyperintense signals in the T2 weighted images, along with a massive diffusion disorder in the diffusion weighted images. This was predominantly in the deep white matter of the parieto-occipital cortex. There were also bilateral hyperintense T2 signals in the ventral globi pallidorum. MR spectroscopy suggested combined hypoxic and mitochondrial damage, resulting in axonal injury without demyelination. He was discharged 1 month later with no hemiplegia. A follow-up MRI scan 6 months later showed improvement. There were no signs of brain atrophy.
According to the authors, this is first reported MRI follow-up study of acute leukoencephalopathy after a single inhaled dose of heroin. It most likely involved a complex mechanism triggered by heroin, causing mitochondrial and hypoxic injury limited to specific areas of the white matter of the brain.
A 21-year-old man became unconscious after smoking heroin at a rave party and developed an aspiration pneumonia, bilateral pyramidal signs, and spastic paresis [ ]. He was given clonidine and midazolam, but continued to have daily episodes of stretching spasms, hyperventilation, profuse sweating, pyrexia, and mydriasis. He was given ubidecarenone 300 mg qds on day 14. A CT scan showed diffuse hypodensities in the white matter indicative of spongiform leukoencephalopathy. On day 30, he began to improve and an MRI scan showed diffuse abnormal lesions in the white matter. He gradually recovered and an MRI scan on day 59 showed less extensive lesions. At 7 months he had regained all functions but had a residual gait ataxia. A follow-up MRI scan showed recovery of the white matter, but some necrosis.
Another report has provided more details from physical assessments and laboratory and radiological (MRI and MRS) data, and more information about the course of this heroin-related effect [ ]. The three cases showed raised concentrations of intracerebral lactate (reflecting mitochondrial dysfunction), which suggests a conversion of aerobic to anaerobic metabolism seen in hypoxic-ischemic conditions, including stroke. One patient recovered quite well after antioxidant therapy, supporting a metabolic effect of the heroin-related toxin; a similar response to co-enzyme Q has been found in other mitochondrial disorders with a high CSF lactate. Thus, the authors recommended that although the role of antioxidant therapy in this condition is unclear, it may be prudent to administer oral co-enzyme Q supplemented with vitamins C and E to patients with this syndrome.
Intravenous administration of pure heroin did not cause a leukoencephalopathy in a patient in whom inhalation had caused it [ ], and toxicity in these cases may have been due to the heating of the heroin. This might have implications for young heroin users who, because of the known increased risk of HIV infection, prefer to “chase” (smoke) the drug, rather than to inject it intravenously.
A 23-year-old pregnant woman at 39 weeks of gestation developed tonic-clonic seizures and hypothermia after taking excessive heroin intravenously [ ]. She developed Cheyne-Stokes respiration needing intubation and a cesarean section was performed, after which she developed inappropriate secretion of antidiuretic hormone and acute renal insufficiency. She made a complete recovery.
The mechanism of heroin-induced spongiform leukoencephalopathy is not known and the disease is not reproducible in animals. Suspicions have been raised about potential contaminants, such as strychnine, caffeine, phenacetin, quinine, and procaine. This man started inhaling heroin 2 weeks before the onset of the disease, but he used it in large amounts, raising the possibility that the severity of the disease is dose-related. In the two cases discussed above, the onset was abrupt, which is not usual. Antioxidant therapy, such as the use of ubidecarenone (coenzyme Q), is supported by its efficacy in previous cases and also because mitochondrial swelling has been reported in patients with such lesions. The authors stressed that there was a favorable outcome with prolonged and supportive care and the use of ubidecarenone, especially in a patient who developed stretching spasms, a feature that has been associated with a very high mortality rate. Because cases occur in clusters, even though many others who inhale heroin do not get this effect, there is suspicion about the possible role of contaminants of small batches of drug by an unknown substance. In addition, some have suggested that heating could be important, since leukoencephalopathy has not been reported with other means of heroin use (until this year, as reported in the next case). The authors of the report postulated that there might be a relation between the amount of heroin inhaled and the severity of the illness. Once symptoms develop, progression continues, usually for 2–3 weeks, but in some individuals it progresses for up to 6 months after exposure. “Coasting,” or the phenomenon of symptom progression after cessation of exposure to toxins, has been observed with other toxins, and it is proposed to result from the storage of toxin in lipid-rich neural or non-neural body tissues, with subsequent release into the bloodstream. Although the “toxin” involved in this condition is unknown, progression could be due to “coasting.” Alternatively, oxidative damage could be initiated by the toxin and produce persistent metabolic changes in the affected white matter. Whatever the mechanism, the illness is extremely grave, with no known treatment and with progression to akinetic mutism and death in about 20% of reported cases.
Spongiform leukoencephalopathy has been described in a 26-year-old after inhalation of heroin [ ]. The diagnosis was confirmed by MRI scan.
A cluster of five cases of toxic leukoencephalopathy over a span of 5 weeks after inhalation of heroin vapor has been reported, with details of three [ ].
A 27-year-old man was found at home in a low state of consciousness after smoking heroin. He developed aphasia and spastic quadriparesis. A CT scan showed symmetrical white matter hypodensity in the cerebellum and symmetrical white matter hypoattenuation in the posterior limb of the internal capsule and optic radiations. An MRI scan showed white matter hypointensity in the cerebellum, with sparing of the cortex and dentate nuclei. There were also hyperintensities in the medial lemnisci and spinothalamic tracts. He died after a seizure 6 weeks later. An autopsy showed spongiform degeneration of the white matter that coincided with the MRI scans.
A 39-year-old man developed bradykinesia and ataxia after smoking heroin. A brain MRI scan showed symmetrically increased signals in the white matter of the cerebellum, the peduncles, and the pons, with sparing of the dentate nuclei. There were abnormal signals in the posterior limb of the internal capsule and optic radiations. The signal abnormalities in this patient were not as pronounced as the previous one, who ultimately died. This patient was also taking methadone in a maintenance program.
A 32-year-old man in a methadone program developed dysarthria, bradykinesia, and ataxia after smoking heroin. CT scans showed symmetric hypodensities in the cerebellum with sparing of the dentate nuclei. There were abnormal signals in the internal capsule and optic radiations., although not as extensive as in those who died.
These cases were typical of toxic leukoencephalopathy secondary to heroin inhalation. Moreover, they had symptoms involving both cerebellum and non-cerebellar structures.
In two reports from China 10 cases (nine men and one woman) of heroin-induced spongiform leukoencephalopathy have been reviewed. The first report discussed six cases with cerebellar signs and symptoms, with symmetrical lesions on neuroimaging in the white matter of the cerebellum, basal ganglia, posterior crus of the internal capsule, and the semi-oval center [ ]. The second report, described four cases that occurred during the abstinence period and showed improvement after 4 weeks of comprehensive treatment [ ].
Two cases of possible toxic leukoencephalopathy following probable inhalation of heroin vapor have been reported [ ].
A 55-year-old man developed confusion, behavioral change, aggression, poor attention, disorientation in time, and impaired short-term memory. He had full ocular movements with no nystagmus, brisk deep tendon reflexes, and bilateral extensor plantar responses. He became progressively drowsy with myoclonic jerks and died 2 weeks later.
A 36-year-old man with a history of substance abuse became unresponsive, with his eyes in mid-position gaze, with pinpoint pupils, brisk deep tendon reflexes, and bilateral extensor plantar responses. On day 9 he spontaneously opened his eyes. However, he died 1 month later with persistent pyrexia from methicillin resistant Staphylococcus aureus .
Neuroimaging and neuropathology in both cases showed diffuse symmetrical degeneration of white matter, with sparing of subcortical U fibers, cerebellum, and brain stem. Toxicology was negative, but was done some time after the report of substance use. In these case reports heroin use could not be confirmed. Although the findings suggested the possibility of heroin toxicity due to inhalation, sparing of the cerebellum and brain stem, frontal predominance of degeneration, and the more prominent axonal involvement are not typical of heroin toxicity, throwing speculation on an unidentified impurity.
A 37-year-old male cocaine abuser was admitted with intoxication, mutism, and substupor [ ]. His toxicological screening was positive for heroin and cocaine. There was spasticity of all limbs and Babinski reflexes. The CSF contained some erythrocytes. The electroencephalogram showed generalized slowing, and a CT scan showed bifrontal confluent hypodensities in the deep white matter. The cranial MRI scan showed diffuse bihemispheric white matter lesions dominantly in the frontal lobe on T2-weighted images. There were abnormal hyperintense lesions in the pyramidal tracts and the corpus callosum. He gradually improved and made a complete recovery within 6 months, as confirmed by neurological and neuropsychological examination.
The findings of toxic leukoencephalopathy in this patient’s brain-imaging studies were similar to those reported in patients who have inhaled impure heroin. However, he had used intravenous heroin and cocaine. This is therefore the first case report of leukoencephalopathy after intravenous use of these drugs. However, it should be noted that the authors did not indicate how the route of drug use was confirmed. They noted that lipophilic substances, such as hexachlorophene or triethylthin, were likely impurities in the abused substances.
A 53-year-old man with a 7-year history of heroin abuse presented with confused speech and unsteady gait [ ]. A CT scan showed low attenuation in the white matter tracts and an MRI scan showed increased signal intensity in the white matter tracts extending from the centrum semiovale, corpus callosum, corona radiata, posterior limbs of the internal capsules, cerebral and cerebellar peduncles, and pyramidal tracts, suggestive of spongiform demyelination. He became bed-bound and tetraplegic and died of a chest infection.
A 37-year-old man, with a short history of heroin and cocaine use, presented with spasticity of all limbs, a confusional state, and mutism [ ]. The electroencephalogram, CT scan, and MRI scan showed predominantly positive frontal pathology, with other lesions in the pyramidal tracts and corpus callosum. The diagnosis was leukoencephalopathy. The symptoms gradually abated after 4 weeks, and repeat tests after 6 months shown to be normal.
Three cases of toxic and progressive spongiform leukoencephalopathy have also been reported as a result of vapor inhalation of heroin [ ]. There were generalized white matter abnormalities and pathology in the cerebellum, internal capsule, corpus callosum, and brain stem.
Heroin-induced leuckoencephalopathy has been misdiagnosed as psychiatric illness [ ].
A 47-year-old woman, with a history of amphetamine abuse, depression, and paranoia, smoked heroin for 4 weeks after stopping amphetamines, and 10 days later became drowsy and confused with increased paranoia and depression. She was disoriented and restless. Her speech was garbled. She had frequent non-purposeful movements and an unsteady gait. A CT brain scan was normal. She was given chlorpromazine, doxepin, and diazepam, but her ataxia and incontinence worsened, her speech and all her movements slowed, with increased tone in all limbs and cogwheel rigidity. Her power and sensation were normal. Truncal ataxia impaired walking. An MRI brain scan showed diffuse high-intensity signals in both cerebral hemispheres, and review of the CT scan showed hypodensities in the same regions. She was treated with co-enzyme Q and regained mobility and continence, but with no improvement in cognitive impairment.
Another form of brain injury, progressive myelopathy, has been reported after inhalation of heroin vapor [ ].
A 46-year-old man chronically abused heroin through inhalation and developed a gait disorder with paresthesia of the legs, incontinence, and impotence. MRI scans showed bilateral subcortical lesions and bilateral signal abnormalities in the corticospinal tract and posterior columns. Motor evoked potentials were slow, with prolonged F wave latency, which is evidence of peripheral nerve disease. Multivitamins and high doses of prednisone did not produce benefit.
This condition was diagnosed as progressive myelopathy affecting only the corticospinal tract and posterior columns, the characteristics of which differ from acute leukoencephalopathy significantly, although both are serious consequences of heroin inhalation. Progressive myelopathy has been reported after heroin insufflation but never after inhalation of vapors. The authors favored an immune mechanism.
Symmetrical deep cerebellar lesions have been associated with heroin smoking [ ].
A 40-year-old man presented to the emergency room after smoking heroin on 2 consecutive days. He complained of unsteadiness and clumsiness. While speaking to a nurse, his condition dramatically worsened, and he became severely ataxic, dysarthric, and clumsy and was unable to stand. An MRI scan showed symmetric bilateral “C-shaped” lesions in the white matter and dentate nuclei of the cerebellum. The diagnosis was toxic leukoencephalopathy secondary to inhaled heroin. Six months later, his cerebellar dysfunction was unchanged.
Because of clustering of cases, it was thought that an additive in the heroin had brought on the symptoms.
Reversible Parkinsonism from heroin vapor inhalation has been reported [ ].
A 38-year-old Caucasian woman, who had taken heroin vapor 2 weeks before, developed confusion, ataxia, and urinary incontinence. She was afebrile and spoke with a slow low-volume monotonous voice. She had marked truncal ataxia with absent postural reflexes, cogwheel rigidity in her limbs, and marked bradykinesia. She had used non-prescription amfetamine up to 4 g/day intermittently for 8 years. After a bout of depression, she came under the care of a psychiatrist and stopped taking amfetamine after she was given chlorpromazine and diazepam. She then started using heroin. In the CSF, protein was raised with normal glucose and lactate; homovanillic acid, a dopamine metabolite, was markedly reduced and the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA) was mildly reduced. Tetrahydrobiopterin was just detectable. She was given co-enzyme Q 30 mg tds and became more alert and began to move and talk. She had recovered fully 1 month later.
According to the authors tetrahydrobiopterin has a range of co-factor roles, including being required for the activity of tyrosine and tryptophan hydroxylase, enzymes that are essential for dopamine and serotonin synthesis. They speculated that something present in the heroin pyrolysate, a product formed when heroin is heated to 250 °C, inhaled by the patient, acted as a reversible inhibitor of tetrahydrobiopterin metabolism, providing a biochemical explanation for impairment of dopamine metabolism and Parkinsonism in this case.
Profound reversible deafness with vestibular dysfunction has been attributed to heroin abuse [ ].
A 47-year-old intravenous opiate user, after a period of abstinence, injected about 0.25 g of illicit diamorphine during a period of 24 hours and developed bilateral symmetrical sensorineural hearing loss, ear fullness, and loud tinnitus 20 minutes later. His symptoms gradually subsided with no sequelae after 3 weeks.
The authors pointed out that bilateral deafness after heroin relapse after prolonged abstinence had been reported in previous two cases, suggesting resensitization of a tolerized opioid system or prolonged hypersensitization of a system in withdrawal.
Seven cases of acute strabismus related to opiate abuse in Switzerland between 1993 and 2001 have been reported [ ]. In five cases the symptoms coincided with heroin withdrawal and acute esotropia occurred a few days after heroin was stopped. The other two patients developed acute exotropia that was related to opiate abuse. All the symptoms disappeared spontaneously. It is likely that changes in the blood opioid concentration disrupted the oculomotor system and affected binocular vision, although the exact mechanism underlying this phenomenon is not known.
A group of 210 young individuals, aged 18–24 years, participating in the Australian Treatment Outcome Study, was studied for longitudinal treatment outcomes of heroin dependency [ ]. There was a high rate of psychiatric co-morbidity, including post-traumatic stress disorder (37%), current major depression (23%), antisocial personality disorder (75%), and borderline personality disorder (51%). While 17% had attempted suicide in the preceding year, 41% had overdosed at some time, 24% in the previous year. First heroin use occurred at age 16.8, first monthly use at age 17.2, and first intravenous use at age 17.4 years. The authors concluded that young heroin users moved to problematic drug use more quickly than did older users. Thus, there is a very limited window during which early intervention can be applied before young heroin users progress to problematic use.
The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) has been attributed to heroin [ ].
A 23-year-old pregnant woman developed antepartum bleeding at 35 weeks and a tonic-clonic convulsion and hypothermia at 39 weeks, having used heroin 4 hours before. She had further tonic-clonic seizures, became obtunded, and required intubation. She had occasional runs of ventricular bigeminy. A cesarean section was performed. The neonate had poor respiratory effort and required ventilation. Blood chemistry suggested inappropriate secretion of antidiuretic hormone, acute renal insufficiency, and acute pancreatitis. She and the baby recovered after 2 weeks.
In a case–control study in 106 heroin-dependent individuals undergoing an opioid detoxification program (n = 19) or a methadone maintenance treatment program (n = 87) there were large significant differences in the mean values of some vitamins and minerals between the heroin-dependent individuals and the healthy, non-dependent controls [ ]. Dependent individuals had higher white cell counts and transaminases and lower erythrocyte counts and cholesterol, albumin, tocopherol, folic acid, sodium, selenium, and copper concentrations.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here